Literature DB >> 9667670

Prognostic value of histological and biological markers in pharyngeal squamous cell carcinoma: a case-control study.

M Guerry1, L Vabre, M Talbot, G Mamelle, A M Leridant, C Hill, J Bosq, B Luboinski, F Janot.   

Abstract

Between 1980 and 1985, 914 patients with head and neck squamous cell carcinoma underwent lymph node dissection in our institution. The prognostic value of clinical factors has already been reported (Mamelle et al, 1994, Am J Surg 168: 494-498). We present here a comparison of biological characteristics of pharyngeal tumours in patients who developed distant metastasis and in patients without metastasis, matched on tumour site, node site and size, and year of diagnosis. Tumour differentiation, keratinization, vascular emboli, immunohistochemical expression of p53, c-erb-B2, Rb and bcl2 were first assessed in 31 pairs of patients. Factors of potential interest were then determined in 32 additional pairs of patients. Statistical analysis showed that the risk of distant metastasis was halved in patients with tumours expressing c-erb-B2 compared with patients with c-erb-B2-negative tumours (P = 0.05). The significance of c-erb-B2 expression and its potential value as a prognostic factor is discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9667670      PMCID: PMC2150341          DOI: 10.1038/bjc.1998.320

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  27 in total

1.  Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer.

Authors:  C J Logothetis; H J Xu; J Y Ro; S X Hu; A Sahin; N Ordonez; W F Benedict
Journal:  J Natl Cancer Inst       Date:  1992-08-19       Impact factor: 13.506

2.  Value of grading squamous cell carcinoma of the head and neck.

Authors:  N J Roland; A W Caslin; J Nash; P M Stell
Journal:  Head Neck       Date:  1992 May-Jun       Impact factor: 3.147

3.  Correlation between p53 gene expression and tumor-cell proliferation in oropharyngeal cancer.

Authors:  J Bourhis; J Bosq; G D Wilson; B Bressac; M Talbot; A M Leridant; R Dendale; N Janin; J P Armand; B Luboinski
Journal:  Int J Cancer       Date:  1994-05-15       Impact factor: 7.396

4.  bcl-2 protein in non-small-cell lung carcinoma.

Authors:  F Pezzella; H Turley; I Kuzu; M F Tungekar; M S Dunnill; C B Pierce; A Harris; K C Gatter; D Y Mason
Journal:  N Engl J Med       Date:  1993-09-02       Impact factor: 91.245

5.  Relationship of C-erbB-2 protein expression and gene amplification to invasion and metastasis in human gastric cancer.

Authors:  T Mizutani; M Onda; A Tokunaga; N Yamanaka; Y Sugisaki
Journal:  Cancer       Date:  1993-10-01       Impact factor: 6.860

6.  Frequent p53 mutations in head and neck cancer.

Authors:  K D Somers; M A Merrick; M E Lopez; L S Incognito; G L Schechter; G Casey
Journal:  Cancer Res       Date:  1992-11-01       Impact factor: 12.701

7.  Expression of c-erbB-2 gene in human head and neck carcinoma.

Authors:  J M Craven; Z P Pavelic; P J Stambrook; L Pavelic; M Gapany; D J Kelley; S Gapany; J L Gluckman
Journal:  Anticancer Res       Date:  1992 Nov-Dec       Impact factor: 2.480

8.  Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression.

Authors:  M F Press; G Hung; W Godolphin; D J Slamon
Journal:  Cancer Res       Date:  1994-05-15       Impact factor: 12.701

Review 9.  Interaction of the neu/p185 and EGF receptor tyrosine kinases: implications for cellular transformation and tumor therapy.

Authors:  W C Dougall; X Qian; M I Greene
Journal:  J Cell Biochem       Date:  1993-09       Impact factor: 4.429

10.  Use of a polyclonal antibody for the determination of the prognostic value of c-erbB-2 protein over-expression in human breast cancer.

Authors:  P Terrier; H Mouriesse; B Loridon; M Gotteland; F May-Levin; J C Delarue
Journal:  Acta Oncol       Date:  1996       Impact factor: 4.089

View more
  3 in total

Review 1.  Clinical implications of biomarkers in head and neck cancer.

Authors:  W M Koch
Journal:  Curr Oncol Rep       Date:  1999       Impact factor: 5.075

Review 2.  acp Best Practice No 169. Evidence based pathology: squamous carcinoma of the hypopharynx.

Authors:  T R Helliwell
Journal:  J Clin Pathol       Date:  2003-02       Impact factor: 3.411

3.  Size, shape, structure, and direction of angiogenesis in laryngeal tumour development.

Authors:  J Laitakari; V Näyhä; F Stenbäck
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.